BibTex RIS Kaynak Göster
Yıl 2014, Cilt: 4 Sayı: 2, 160 - 166, 01.06.2014

Öz

Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections

Yıl 2014, Cilt: 4 Sayı: 2, 160 - 166, 01.06.2014

Öz

The purpose of this study is to show how a private eye care center in Turkey initiated Six Sigma principles to reduce the number of complications encountered during and after intravitreal injections. Data were collected for 30-months. To analyse the complications among 229 injections administered on 106 patients, main tools of Six Sigma’s Define-Measure-Analyze-Improve-Control (DMAIC) improvement cycle such as SIPOC table, Fishbone Diagram and, Failure, Mode and Effect Analysis were implemented. Sources and root causes of seven types of complications were identified and reported. For a successful intravitreal injection, experience of the retina specialist, attention of the retina specialist and patient’s ocular pathology were determined to be the “critical few” factors whereas, sterilization and hygiene, dosage of drug/agent and chemical properties of drug/agent were found to be the “trivial many”factors. The most frequently occuring and the complication with the highest hazard score was found to be subconjunctival haemorrhage. The process sigma level of the process was measured to be 3.2657. The surgical team concluded that six of the complications (out of seven) should be significantly reduced by taking the necessary preventative measures.

Toplam 0 adet kaynakça vardır.

Ayrıntılar

Diğer ID JA97NK77PJ
Bölüm Araştırma Makalesi
Yazarlar

İbrahim Sahbaz Bu kişi benim

Mehmet Tolga Taner Bu kişi benim

Mustafa Elıacık Bu kişi benim

Gamze Kagan Bu kişi benim

Engin Erbas Bu kişi benim

Hazar Engunyurt Bu kişi benim

Yayımlanma Tarihi 1 Haziran 2014
Yayımlandığı Sayı Yıl 2014 Cilt: 4 Sayı: 2

Kaynak Göster

APA Sahbaz, İ., Taner, M. T., Elıacık, M., Kagan, G., vd. (2014). Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. International Review of Management and Marketing, 4(2), 160-166.
AMA Sahbaz İ, Taner MT, Elıacık M, Kagan G, Erbas E, Engunyurt H. Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. IRMM. Haziran 2014;4(2):160-166.
Chicago Sahbaz, İbrahim, Mehmet Tolga Taner, Mustafa Elıacık, Gamze Kagan, Engin Erbas, ve Hazar Engunyurt. “Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections”. International Review of Management and Marketing 4, sy. 2 (Haziran 2014): 160-66.
EndNote Sahbaz İ, Taner MT, Elıacık M, Kagan G, Erbas E, Engunyurt H (01 Haziran 2014) Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. International Review of Management and Marketing 4 2 160–166.
IEEE İ. Sahbaz, M. T. Taner, M. Elıacık, G. Kagan, E. Erbas, ve H. Engunyurt, “Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections”, IRMM, c. 4, sy. 2, ss. 160–166, 2014.
ISNAD Sahbaz, İbrahim vd. “Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections”. International Review of Management and Marketing 4/2 (Haziran 2014), 160-166.
JAMA Sahbaz İ, Taner MT, Elıacık M, Kagan G, Erbas E, Engunyurt H. Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. IRMM. 2014;4:160–166.
MLA Sahbaz, İbrahim vd. “Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections”. International Review of Management and Marketing, c. 4, sy. 2, 2014, ss. 160-6.
Vancouver Sahbaz İ, Taner MT, Elıacık M, Kagan G, Erbas E, Engunyurt H. Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. IRMM. 2014;4(2):160-6.